Sugi Predict

Sugi Predict / Compounds / SCHEMBL2649005

SCHEMBL2649005

SCHEMBL2649005

CC(C)(Sc1cnc(NC(=O)N(C2CCCC2)[C@H]2CC[C@H](C(C)(C)C)CC2)s1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.43
▸ CDK2 P24941 10/20 0.36
▸ CCNE2 O96020 9/20 0.36
▸ CCNE1 P24864 9/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ CCNB2 O95067 3/20 0.33
▸ CDK1 P06493 3/20 0.33
▸ CDK4 P11802 3/20 0.33
▸ CCNB1 P14635 3/20 0.33
▸ CCND1 P24385 3/20 0.33
▸ CCNB3 Q8WWL7 3/20 0.33
▸ CDK9 P50750 3/20 0.33
▸ CIT O14578 1/20 0.33
▸ CASK O14936 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ GAK O14976 1/20 0.33
▸ DCLK1 O15075 1/20 0.33
▸ MAP3K7 O43318 1/20 0.33
▸ CCNT1 O60563 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2649008 1.00 RAB9A (0.43) RAB9ACDK2CCNE2CCNE1SMN1; SMN2
SCHEMBL2648401 0.99 RAB9A (0.43) RAB9ACDK2CCNE2CCNE1SMN1; SMN2
SCHEMBL2648404 0.99 RAB9A (0.43) RAB9ACDK2CCNE2CCNE1SMN1; SMN2
SCHEMBL2649802 0.93 CDK2 (0.41) RAB9ACDK2CCNE2CCNE1SMN1; SMN2
SCHEMBL1000423 0.90 CDK2 (0.38) CDK2CCNE2CCNE1SMN1; SMN2CCNB2
SCHEMBL1000421 0.90 CDK2 (0.38) CDK2CCNE2CCNE1SMN1; SMN2CCNB2
SCHEMBL2647706 0.87 CCNE1 (0.36) CDK2CCNE2CCNE1SMN1; SMN2CCNB2
SCHEMBL2648978 0.87 CCNE1 (0.36) CDK2CCNE2CCNE1SMN1; SMN2CCNB2
SCHEMBL2647707 0.87 CCNE1 (0.36) CDK2CCNE2CCNE1SMN1; SMN2CCNB2
SCHEMBL2648983 0.87 CCNE1 (0.36) CDK2CCNE2CCNE1SMN1; SMN2CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582769-B2 Dicycloalkyl urea glucokinase activators NOVO NORDISK A/S (DK) 2009-09-01 — — US disclosed
US-7582769-B2 Dicycloalkyl urea glucokinase activators NOVO NORDISK A/S (DK) 2009-09-01 — — US disclosed
US-7582769-B2 Dicycloalkyl urea glucokinase activators NOVO NORDISK A/S (DK) 2009-09-01 — — US disclosed
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-05-07 — — US disclosed
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-05-07 — — US disclosed
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2009-05-07 — — US disclosed
EP-1904466-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS Novo Nordisk A/S (DK) 2008-04-02 — — EP disclosed
WO-2007006760-A1 DICYCLOALKYL UREA GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2007-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118501-A1 Dicycloalkyl Urea Glucokinase Activators GCK, GCKR, UCK2 RAB9A 2950/4885CDK2 253/4885CCNE2 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.